newsfilter
← Latest News
GlobeNewswire·

Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026

MIAMI, June 15, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) OPKO Biologics, an OPKO Health company, presented preclinical data for OPK8801001 at ENDO 2026, the Endocrine Society's annual meeting. The